Jianpijiedu Fang improves survival of hepatocarcinoma mice by affecting phosphatase and tensin homolog, phosphoinositide 3-kinase, and focal adhesion kinase

Journal of Traditional Chinese Medicine

Volumn 33, Issue 4, 2013, Pages 479-485

  Sun, Baoguo ^a   Meng, Jun ^a   Xiang, Ting ^a   Chen, Zexiong ^a   Li, Yulong ^a   Lu, Lisha ^a   Zhang, Shijun ^a   Chen, Xiaolin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Focal adhesion protein tyrosine kinases; Jianpijiedu Fang; Liver neoplasms; Phosphatidylinositol 3 kinase; Pten protein, mouse

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; FOCAL ADHESION KINASE; JIANPIJIEDU FANG; PHOSPHATIDYLINOSITOL 3 KINASE; TEGAFUR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER SURVIVAL; CANCER TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SURVIVAL RATE; WEIGHT REDUCTION;

ANIMALS; DRUGS, CHINESE HERBAL; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICROFILAMENT PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORIC MONOESTER HYDROLASES;

EID: 84883020423     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Altekruse S F, McGlynn K A, Reichman M E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27(9):1485-1491.
2. Yuen M F, Hou J L, Chutaputti A, et al. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 2009;24(3):346-353.
3. Tang Z Y. Combination of Traditional Chinese Medicine and Western Medicine in the treatment of liver cancer. Lin Chuang Gan Dan Bing Za Zhi 2011; 27(5): 129-130.
4. Huang Z F, Li H Z, Zhang Z J, et al. Jianpixiaoji decoction's effect to the patients' quality of live with late primary liver cancer. Zhong Hua Zhong Xi Yi Jie He Xiao Hua Za Zhi 2010;18(1):47-48, 50.
5. Zender L, Villanueva A, Tovar V, et al. Cancer gene discovery in hepatocellular carcinoma. J Hepatol 2010; 52(6):921-929.
6. Sze K M, Wong K L, Chu G K, et al. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix met alloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology 2011; 53(5):1558-1569.
7. Luedde T. MicroRNA-151and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma. Hepatology 2010; 52(3):1164-1166.
8. Zhao J, Guan J L. Signal transduction by focal adhesion kinase in cancer. Cancer and Metastasis Rev 2009; 28(1-2): 35-49.
9. Leslie N R, Bennett D, Lindsay Y E. et al. Redox regulation of PI3-kinase signalling via inactivation of PTEN. EMBO J 2003;22(20):5501-5510.
10. Sun B G, Zhang S J, Liu Y D, et al. Establishing human hepatoma model from subcutane to orthotopic transplantation with Be-l7402cells in athymic mice and PTEN expression. Chin J Integr T rad West Med Dig 2007; 15(5): 297-301.
11. Peyrou M, Bourgoin L, Foti M. PTEN in liver diseases and cancer. World J Gastroenterol 2010; 16(37): 4627-4633.
12. Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesionsby tumor suppressor PTEN. Science 1998;280(5369):1614-1617.
13. Yuan T L, Cantley L C. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008; 27(41): 5497-5510.
14. Shen W H, Balajee A S, Wang J, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007;128(1):157-170.
15. Kotelevets L, van Hengel J, Bruyneel E, et al. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 2005;19(1):115-117.
16. Vinciguerra M, Carrozzino F, Peyrou M, et al. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol 2009;50(6):1132-1141.
17. Schwock J, Dhani N, Hedley D W. Targeting focal adhesion kinase signaling in tumor growth and metastasis. Expert Opin Ther Targets 2010;14(1):77-94.
18. Cai L, Han J, Zhuo X, et al. Overexpression and significance of focal adhesion kinase in hepatocellular carcinoma and its relationship with HBV infection. Med Oncol 2009;26(4):409-414.
19. Leslie N R, Yang X, Downes C P, et al. The regulation of cell migration by PTEN. Biochem Soc Trans 2005; 33(6): 1507-1508.
20. Capodanno A, Camerini A, Orlandini C, et al. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma. Hum Pathol 2009;40(10):1408-1417.
21. Jiang B H, Liu L Z. AKT signaling in regulating angiogenesis. Curr Cancer Drug Targets 2008;8(1):19.